Press Releases Cassava Sciences, Inc.

Equities

SAVA

US14817C1071

Market Closed - Nasdaq Other stock markets 01:30:00 11/05/2024 am IST			5-day change	1st Jan Change
20.23 ^USD	-4.17%		-8.25%	-10.13%

10/05	Cassava Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
08/05	Cassava Sciences Raises More Than $125 Million From Warrant Distribution	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam	11/05	GL
Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution	08/05	GL
Cassava Sciences : Warrants – Notice of Guaranteed Delivery	02/05	PU
Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ	01/05	GL
Cassava Sciences : Corporate Presentation – Second Quarter 2024	25/04	PU
Cassava Sciences, Inc. - Redemption Date Announced for Warrants	16/04	AQ
Redemption Date Announced for Warrants	15/04	GL
Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava	29/03	PR
ROSEN, A LONGSTANDING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important April 2 Deadline in Securities Class Action - SAVA	28/03	PR
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA	27/03	PR
Cassava Sciences : Corporate Presentation – First Quarter 2024	25/03	PU
Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials	25/03	GL
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava	21/03	PR
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA	21/03	PR
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA	20/03	NE
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA	20/03	PR
ROSEN, A TOP RANKED LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA	18/03	NE
ROSEN, A LEADING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA	15/03	NE
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava	13/03	PR
Thinking about buying stock in Lexicon Pharmaceuticals, Cassava Sciences, Clearside Biomedical, Lantern Pharma, or ATAI Life Sciences?	13/03	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Cassava Sciences, Inc.

Equities

SAVA

US14817C1071

Press Releases

Filters